Rebound phenomenon is most commonly seen with use of_________________?
A. Eephrine
B. Noreephrine
C. Phenyleprine
D. Leuonordefrin
Pharmacology
The anticogulant of choice during pregnancy is______________?
The anticogulant of choice during pregnancy is______________?
A. Warfarin sodium
B. Sodium oxalate
C. Heparin
D. Phenindone
Identify the factors which decrease the effect of Oral anticoagulants_______________?
Identify the factors which decrease the effect of Oral anticoagulants_______________?
A. Pregnancy
B. Nephrotic syndorme
C. Newborn
D. Liver disease
E. Both A & B
The highest risk associated with use of oral contraceptives in________________?
The highest risk associated with use of oral contraceptives in________________?
A. Hepatic necrosis
B. Permanent sterility
C. Thromboembolic disorders
D. Cancer of breast
Which of the following drugs is not hypoglycemic?
Which of the following drugs is not hypoglycemic?
A. Ethosuxinide
B. Tolbutamide
C. Glibenclamide
D. Gluengon
Steroids________________?
Steroids________________?
A. Steroids reduce the rate of repair of tissues thus delays the healing
B. Exacerbate the inflammatory response
C. Can be safely given to immunocompromised patients
D. Indicated in oral thrush
Which of the following is a vosoconstrictor______________?
Which of the following is a vosoconstrictor______________?
A. Bupivacaine
B. Procaine
C. Lidocaine
D. None of the above
Warfarin therapy is prolonged by all except______________?
Warfarin therapy is prolonged by all except______________?
A. Rifampicin
B. Amoxycillin
C. Erythromycin
D. Tetracycline
Excessive bleeding due to heparin overdose is controlled by______________?
Excessive bleeding due to heparin overdose is controlled by______________?
A. Protamine sultate
B. Vitamin K
C. Factor VIII
D. EADA
Heparin, apart from releasing lypoprotein lipase in the blood exerts its anti-coagulant action by____________?
Heparin, apart from releasing lypoprotein lipase in the blood exerts its anti-coagulant action by____________?
A. Binding to calcium
B. Inhibiting fibrinogen synthesis
C. Inhibiting prothrombin synthesis
D. Inhibiting thrombin synthesis